MorphoSys AG: MorphoSys Presents Preliminary Results from Ph

The findings, including encouraging preliminary efficacy data in various tumor types, were presented during the 34th EORTC-NCI-AACR SymposiumPLANEGG/MUNICH, GERMANY / ACCESSWIRE / October 27, 2022 / MorphoSys

Related Keywords

Germany , United States , Planegg , Bayern , Massachusetts , Washington , Boston , Sweden , Spain , Barcelona , Comunidad Autonoma De Cataluna , Swedish , American , Thomas Biegi , Tim Demuth , Julia Neugebauer , Eamonn Nolan , Charles Drescher , Morphosys Agview , Gynecologic Cancer Research , Swedish Cancer Institute In Seattle , Development Officer , Linkedin , National Cancer Institute , Twitter , European Organisation For Research , Exchange Commission , American Association For Cancer Research , Molecular Targets , Cancer Therapeutics , European Organisation , American Association , Cancer Research , Gynecologic Oncologist , Medical Director , Swedish Cancer Institute , Morphosys Chief Research , Morphosy Annual Report , Morphosys , Presents , Reliminary , Results , Rom , Hase , Study , Tulmimetostat , Supporting , Potential , Application , Road , Array , Dvanced , Rumors ,